Del-desiran

del-desiran · Avidity Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Del-desiran, covering 2026-01-22 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 [Phase 3]